Mar 03, · AJ Littman, LC Bertram, R Ceballos, etal: Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: Effects on quality of life and anthropometric measures Support Care Cancer – , Crossref, Medline, Google ScholarCited by: A review of the literature and expert opinion by the European Group for Breast Cancer Screening concluded that “there is little evidence to support the use of ultrasound in population breast cancer screening at any age.” The Japan Strategic Anti-cancer Randomized Trial (J-START) is a screening trial that randomly assigned women aged 40 to.
Abstracts: San Antonio Breast Cancer Virtual Symposium; December , ; San Antonio, Texas Introduction: Tamoxifen prevents breast cancer in high-risk women and reduces recurrence in the adjuvant setting but comes with side-effects. The optimal dose to increase uptake and retain therapeutic effect is unknown. We tested if the efficacy of low-dose tamoxifen is non-inferior to standard. Jan 29, · This trial aims to test whether Optimune, a novel Internet intervention we developed for that purpose, leads to improvements in quality of life and relevant lifestyle habits over the course of 3 to 6 months. This randomized controlled trial (RCT) will include female breast cancer survivors who have completed the active tumour eradication phase.
This study was an open-label, randomized controlled study with a treatment selection design in which a noninferiority criterion was predefined. Patients aged years with surgically treated human epidermal growth factor receptor 2–positive invasive breast cancer received trastuzumab monotherapy or trastuzumab + xbreast.xyz: Masataka Sawaki, Naruto Taira, Yukari Uemura, Tsuyoshi Saito, Shinichi Baba, Kokoro Kobayashi, Hiroa. October and August , we conducted a single-blind, randomized controlled trial of twice weekly slowly progressive weight lifting or standard care among non-metastatic breast cancer survivors. ASMM was quantified using dual-energy X-ray absorptiometry. Changes in ASMM were evaluated from baseline to 12 monthsCited by:
The Breast Research Initiative for Determining Effective Strategies for Coping With Breast Cancer (BRIDGES) is a randomized clinical trial (RCT) of women diagnosed with BrCA. We did a randomised controlled trial in women having potentially curative primary breast cancer resections. Our study was designed specifically to ascertain whether regional anaesthesia-analgesia with paravertebral blocks and propofol sedation reduces breast cancer recurrence compared with general anaesthesia with the volatile anaesthetic sevoflurane and opioid xbreast.xyz by: